Michal Vrablik

8PUBLICATIONS
73CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionMajor global burdens of diseaseSocial determinants of healthCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 30, 2026
Effect of APOC3 Inhibition With Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.

Nicholas A Marston, Brian A Bergmark, Thomas A Prohaska

|Jan 07, 2026
GLP-1 Receptor Agonists for Secondary Prevention After Myocardial Infarction and Stroke in Type 2 Diabetes: Nationwide Real-World Evidence.

Petra Sedova, Michal Vrablík, Petr Kala

|Nov 17, 2025
The European Program for Prevention (EPP) - Implementing Proven Preventing Measures Now!

Maciej Banach, Zlatko Fras, Dan Gaita

|Jun 25, 2025
Statin adherence improves with age and subsequent treatment sequences: A retrospective cohort study using Proportion of Days Covered (PDC).

Aleš Tichopád, Gleb Donin, Jan Žigmond

|Jun 06, 2023
Cardiovascular risk in myositis patients compared with the general population.

Sabina Oreska, Hana Storkanova, Aneta Pekacova

|May 22, 2023
Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias.

Michal Vrablík, Ivana Šarkanová, Katarína Breciková

Pageof 2

Frequent Collaborators

3 joint publications

Maciej Banach

3 joint publications

Petra Šedová

2 joint publications

Aleš Tichopád

1 joint publications

Niki Katsiki